Overview
Mingwei Fu practices practicing medicine in Tianjin, China.
Their clinical expertise encompasses Non-Hodgkin Lymphoma, Multiple Myeloma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mingwei Fu
Is Mingwei Fu a top-rated expert for Bone Marrow Transplant?
MediFind is an objective health platform that identifies experts based on real-world data. Mingwei Fu is classified as an Experienced expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mingwei Fu participate in research or clinical trials?
Yes. Mingwei Fu has published 11 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Mingwei Fu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone Marrow TransplantFu isExperienced. Learn about Bone Marrow Transplant.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Multiple MyelomaFu isExperienced. Learn about Multiple Myeloma.
- Non-Hodgkin LymphomaFu isExperienced. Learn about Non-Hodgkin Lymphoma.